協和キリンの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2024/09/26 | 2,694 | 2,699.5 | 2,602.5 | 2,612.5 | -81 | -3% | 6,381,300 |
| 2024/09/25 | 2,670 | 2,751.5 | 2,632 | 2,693.5 | -406.5 | -13.1% | 9,652,300 |
| 2024/09/24 | 3,208 | 3,218 | 3,071 | 3,100 | -109 | -3.4% | 2,238,900 |
| 2024/09/20 | 3,263 | 3,282 | 3,178 | 3,209 | -21 | -0.7% | 1,792,300 |
| 2024/09/19 | 3,296 | 3,301 | 3,194 | 3,230 | -22 | -0.7% | 1,544,500 |
| 2024/09/18 | 3,270 | 3,313 | 3,226 | 3,252 | -15 | -0.5% | 1,055,400 |
| 2024/09/17 | 3,254 | 3,275 | 3,215 | 3,267 | +13 | +0.4% | 1,366,600 |
| 2024/09/13 | 3,270 | 3,299 | 3,217 | 3,254 | -23 | -0.7% | 1,639,500 |
| 2024/09/12 | 3,270 | 3,294 | 3,251 | 3,277 | +51 | +1.6% | 1,181,900 |
| 2024/09/11 | 3,230 | 3,254 | 3,203 | 3,226 | +28 | +0.9% | 1,247,500 |
| 2024/09/10 | 3,224 | 3,252 | 3,195 | 3,198 | -58 | -1.8% | 1,370,800 |
| 2024/09/09 | 3,167 | 3,258 | 3,155 | 3,256 | +54 | +1.7% | 1,220,700 |
| 2024/09/06 | 3,215 | 3,257 | 3,200 | 3,202 | -2 | -0.1% | 822,100 |
| 2024/09/05 | 3,229 | 3,268 | 3,192 | 3,204 | -56 | -1.7% | 855,200 |
| 2024/09/04 | 3,244 | 3,320 | 3,240 | 3,260 | -42 | -1.3% | 1,165,900 |
| 2024/09/03 | 3,283 | 3,311 | 3,268 | 3,302 | +19 | +0.6% | 615,000 |
| 2024/09/02 | 3,298 | 3,314 | 3,255 | 3,283 | -42 | -1.3% | 681,400 |
| 2024/08/30 | 3,308 | 3,325 | 3,269 | 3,325 | +25 | +0.8% | 2,780,700 |
| 2024/08/29 | 3,320 | 3,350 | 3,293 | 3,300 | -10 | -0.3% | 935,000 |
| 2024/08/28 | 3,300 | 3,316 | 3,283 | 3,310 | +10 | +0.3% | 961,200 |
| 2024/08/27 | 3,272 | 3,300 | 3,245 | 3,300 | +46 | +1.4% | 822,000 |
| 2024/08/26 | 3,221 | 3,259 | 3,163 | 3,254 | -5 | -0.2% | 1,012,900 |
| 2024/08/23 | 3,175 | 3,264 | 3,175 | 3,259 | +101 | +3.2% | 1,247,300 |
| 2024/08/22 | 3,100 | 3,169 | 3,093 | 3,158 | +46 | +1.5% | 1,100,100 |
| 2024/08/21 | 3,123 | 3,143 | 3,104 | 3,112 | -28 | -0.9% | 721,600 |
| 2024/08/20 | 3,128 | 3,159 | 3,109 | 3,140 | +52 | +1.7% | 850,000 |
| 2024/08/19 | 3,125 | 3,136 | 3,068 | 3,088 | -72 | -2.3% | 940,400 |
| 2024/08/16 | 3,094 | 3,164 | 3,090 | 3,160 | +109 | +3.6% | 1,105,000 |
| 2024/08/15 | 3,047 | 3,086 | 3,046 | 3,051 | -28 | -0.9% | 841,600 |
| 2024/08/14 | 3,079 | 3,092 | 3,015 | 3,079 | +38 | +1.2% | 1,083,600 |
| 2024/08/13 | 3,014 | 3,065 | 2,983.5 | 3,041 | +74.5 | +2.5% | 1,484,100 |
| 2024/08/09 | 3,002 | 3,023 | 2,905.5 | 2,966.5 | +5 | +0.2% | 1,389,100 |
| 2024/08/08 | 2,962 | 3,021 | 2,934.5 | 2,961.5 | +9.5 | +0.3% | 1,228,900 |
| 2024/08/07 | 2,974 | 3,044 | 2,874 | 2,952 | -63 | -2.1% | 1,566,000 |
| 2024/08/06 | 2,909.5 | 3,059 | 2,871.5 | 3,015 | +197.5 | +7% | 2,196,100 |
| 2024/08/05 | 2,987 | 3,044 | 2,797 | 2,817.5 | -239.5 | -7.8% | 1,977,900 |
| 2024/08/02 | 3,083 | 3,177 | 3,045 | 3,057 | -60 | -1.9% | 1,690,000 |
| 2024/08/01 | 3,154 | 3,178 | 3,082 | 3,117 | -62 | -2% | 948,500 |
| 2024/07/31 | 3,127 | 3,196 | 3,120 | 3,179 | +14 | +0.4% | 798,500 |
| 2024/07/30 | 3,183 | 3,190 | 3,150 | 3,165 | -9 | -0.3% | 609,500 |
| 2024/07/29 | 3,155 | 3,206 | 3,147 | 3,174 | +19 | +0.6% | 730,900 |
| 2024/07/26 | 3,150 | 3,185 | 3,150 | 3,155 | +39 | +1.3% | 852,500 |
| 2024/07/25 | 3,110 | 3,153 | 3,100 | 3,116 | -33 | -1% | 954,400 |
| 2024/07/24 | 3,159 | 3,197 | 3,142 | 3,149 | -49 | -1.5% | 699,500 |
| 2024/07/23 | 3,165 | 3,206 | 3,159 | 3,198 | +27 | +0.9% | 683,200 |
| 2024/07/22 | 3,196 | 3,206 | 3,153 | 3,171 | +1 | ±0% | 700,700 |
| 2024/07/19 | 3,126 | 3,180 | 3,106 | 3,170 | +5 | +0.2% | 658,100 |
| 2024/07/18 | 3,170 | 3,195 | 3,152 | 3,165 | -13 | -0.4% | 833,800 |
| 2024/07/17 | 3,177 | 3,196 | 3,148 | 3,178 | +78 | +2.5% | 1,078,500 |
| 2024/07/16 | 3,122 | 3,140 | 3,079 | 3,100 | -7 | -0.2% | 649,400 |
151～
200
件表示中 / 3697件
類似銘柄と比較する
現在ご覧いただいている「協和キリン」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 協和キリン | 221,800円 | -3.5% | -11.3% | 2.71% | 20.37倍 | 1.36倍 |
|
キリン傘下。医薬品、バイオが主力。独自の抗体高活性化技術に強み。富士フイルムと提携 |
| 塩野義 | 223,100円 | +20.9% | +10.6% | 2.96% | 10.55倍 | 1.39倍 |
|
抗ＨＩＶ薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
| エーザイ | 399,900円 | +1.7% | -2.9% | 4.00% | 26.24倍 | 1.38倍 |
|
神経系、がん領域に強み。認知症薬は米バイオジェンと、抗がん薬では米メルクと国際協業推進 |
| 小野薬 | 154,700円 | +0.6% | +43.3% | 5.17% | 10.85倍 | 0.93倍 |
|
医療用医薬品専業の中堅。自社開発品多い。先駆的がん免疫阻害剤「オプジーボ」が成長牽引 |
| ロート | 244,100円 | +18.2% | +4.2% | 1.47% | 17.13倍 | 2.18倍 |
|
一般用医薬品の目薬で世界首位。「肌研」が急成長しスキンケアが柱に。アジアなど海外積極進出 |
市場注目の銘柄
チャート関連のコラム
